Osteoporosis in men: a review (Q35755160)

10 August 2017

title

Osteoporosis in men: a review (English)

1 reference

10 August 2017

0 references

Robert A Adler

1 reference

10 August 2017

publication date

29 April 2014

1 reference

10 August 2017

1 reference

10 August 2017

1 reference

10 August 2017

page(s)

14001

1 reference

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

10 August 2017

start time

29 April 2014

1 reference

April 2022 Public Data File from Crossref

copyrighted

0 references

cites work

Definition of osteoporosis by bone density criteria in men: effect of using female instead of male young reference data depends on skeletal site and densitometer manufacturer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

2013 International Society for Clinical Densitometry Position Development Conference: Task Force on Normative Databases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Circulating sclerostin levels and markers of bone turnover in Chinese-American and white women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

The pathogenesis, treatment and prevention of osteoporosis in men.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Androgen prevents hypogonadal bone loss via inhibition of resorption mediated by mature osteoblasts/osteocytes

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Sarcopenia and its relationship with bone mineral density in middle-aged and elderly European men.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Osteoporosis in men: an Endocrine Society clinical practice guideline

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Laboratory testing for secondary osteoporosis evaluation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Therapy of osteoporosis in men with teriparatide

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Official Positions for FRAX® clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Glucocorticoid-induced osteoporosis in men

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Estimation of the lifetime risk of hip fracture for women and men in Canada.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Mechanical contributions of the cortical and trabecular compartments contribute to differences in age-related changes in vertebral body strength in men and women assessed by QCT-based finite element analysis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Towards a diagnostic and therapeutic consensus in male osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Screening for Osteoporosis: U.S. Preventive Services Task Force Recommendation Statement

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Management of osteoporosis in men on androgen deprivation therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Using clinical risk factors and bone mineral density to determine who among patients undergoing bone densitometry should have vertebral fracture assessment.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Meta-analysis: excess mortality after hip fracture among older women and men.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Bone mineral density and prevalent osteoarthritis of the hip in older men for the Osteoporotic Fractures in Men (MrOS) Study Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Survival following primary androgen deprivation therapy among men with localized prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Adherence to alendronate in male veterans

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Development of a nomogram for individualizing hip fracture risk in men and women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Residual lifetime risk of fractures in women and men.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Bone loss in elderly men: increased endosteal bone loss and stable periosteal apposition. The prospective MINOS study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Practice patterns in patients at risk for glucocorticoid-induced osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Secondary causes of osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Involutional osteoporosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Association between serum insulin growth factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Risk-adjusted mortality rates of elderly veterans with hip fractures.

27 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

High-trauma fractures and low bone mineral density in older women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Perturbed sex steroid status in men with idiopathic osteoporosis and their sons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Serum testosterone, dihydrotestosterone and estradiol concentrations in older men self-reporting very good health: the healthy man study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Osteoporosis in men: the value of laboratory testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Secondary osteoporosis in men and women: clinical challenge of an unresolved issue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Secondary fracture prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

The effects of a FRAX revision for the USA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Efficacy and safety of monthly ibandronate in men with low bone density

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Fracture risk and zoledronic acid therapy in men with osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

A randomized, placebo-controlled study of the effects of denosumab for the treatment of men with low bone mineral density.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Efficacy and safety of strontium ranelate in the treatment of osteoporosis in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Nationwide registry-based analysis of cardiovascular risk factors and adverse outcomes in patients treated with strontium ranelate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Treatment of osteoporosis in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

United States life tables, 2007.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4472130

Oral corticosteroids and fracture risk: relationship to daily and cumulative doses

25 September 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Alendronate for the Treatment of Osteoporosis in Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

Do men and women fracture bones at similar bone densities?

21 January 2018

1 reference

12 December 2020

Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer

1 reference

12 December 2020

Risk of Subsequent Fracture After Low-Trauma Fracture in Men and Women

1 reference

12 December 2020

Risk of fracture after androgen deprivation for prostate cancer

1 reference

12 December 2020

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study

1 reference

12 December 2020

Primary care and public health a natural alliance? The introduction of the guidelines for obesity and undernutrition of the Dutch College of General Practitioners

1 reference

https://api.crossref.org/works/10.1038%2FBONERES.2014.1

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1038/BONERES.2014.1

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/peqwyszqovg4hdw24cj3kgzmee

30 July 2022

release_peqwyszqovg4hdw24cj3kgzmee

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/peqwyszqovg4hdw24cj3kgzmee

30 July 2022

https://api.fatcat.wiki/v0/release/peqwyszqovg4hdw24cj3kgzmee

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/peqwyszqovg4hdw24cj3kgzmee

1 reference

30 July 2022